Pharmaceutical company Strides Arcolab has launched an anti-swine flu drug.
The company has launched Starflu capsule, the cure for swine flu, the pharma firm said in a filing to the Bombay Stock Exchange.
Starflu is the generic version for Tamiflu-Oseltamivir and is available at all licensed pharmacies at a maximum retail price of Rs 460 for a bottle of 10 capsules, it further said.
"Strides has the requisite stocks of Starflu to adequately supply and service the retail demand for this drug," Strides Arcolab President Nitin Ghadiyar said.
The company's move is subsequent to the Indian Government's approval of restricted retail sale of Oseltamivir (tamiflu) for H1N1 treatment, it added.
Shares of Strides Arcolab were trading at Rs 175.05 on BSE, up 6.87 per cent from previous close.
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors
Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share
Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor
Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements
Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app